Josh Enomoto

Josh Enomoto

InvestorPlace Contributor

Brokering multi-million-dollar deals with some of the world’s biggest companies and providing in-depth marketing analyses, Josh Enomoto takes his firsthand knowledge of the corporate boardroom and delivers them across several media outlets. In addition to his work at InvestorPlace, Josh contributes content for Benzinga, TipRanks, EmergingGrowth and Blockster. He is also a guest expert at CGTN America.

While leaving no stone unturned regarding sector coverage, Josh has written extensively about cryptocurrencies. You can follow him on Blockster, a crypto-centric social media platform and on LinkedIn.

Recent Articles

Novavax Investors Must Look Beyond the Headlines

By Josh Enomoto, InvestorPlace Contributor

There’s no doubting that Novavax offers an exciting new technology for a coronavirus vaccine candidate. However, NVAX stock is a trickier once you look beyond the headlines.

Nokia Stock Is Set for a Dramatic Q2 Earnings Reveal

By Josh Enomoto, InvestorPlace Contributor

With the U.S. and China at each other’s throat, this dynamic seemingly benefits Nokia stock ahead of Q2. However, investors should investigate all angles before placing a wager.

Science Is the Reason to Invest in Neurotez Stock

By Josh Enomoto, InvestorPlace Contributor

Neurotez is taking a new approach to addressing Alzheimer’s disease, a condition that is increasingly affecting millions of Americans. Therefore, you may want to invest in Neurotez stock.

Ford Is Setting Up an Electrifying Q2 Report

By Josh Enomoto, InvestorPlace Contributor

For once, Ford’s earnings results is the least-interesting topic. Instead, the trajectory of F stock will depend on the upcoming all-electric Ford Mustang Mach-E.

Ayro Inc Is Picture-Perfect, Except for One Nagging Detail

By Josh Enomoto, InvestorPlace Contributor

If AYRO stock were to exist in a non-pandemic state, this would be a perfect buy. But because the pandemic is real, the case for the EV specialist becomes much trickier.

Load More